Navigation Links
InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
Date:2/26/2009

8 18,272 13,272 Total revenue, net 7,401 9,627 48,152 66,692 Costs and expenses: Cost of goods sold 1,713 2,058 8,989 14,109 Research and development 26,274 25,106 104,581 105,939 General and administrative 7,795 6,611 30,260 29,577 Acquired research and development milestone - 6,225 - 13,725 Restructuring charges - - - 10,246 Total costs and expenses 35,782 40,000 143,830 173,596 Loss from operations (28,381) (30,373) (95,678) (106,904) Interest income 972 2,945 5,616 10,699 Interest expense (1,534) (696) (5,635) (2,881) Other income (expense) (3,431) (111) (2,145) 2,215 Loss from continuing operations before income taxes (32,374) (28,235) (97,842) (96,871) Income tax expense/(benefit) - (2,275) - (2,275) Loss from continuing operations (32,374) (25,960) (97,842) (94,596) Discontinued operations: Income (loss) from discontinued operations 32 79 103 4,994 Net loss $(32,342) $(25,881) $(97,739) $(89,602) Basic and diluted loss per share: Continuing operations $(0.83) $(0.67) $(2.51) $(2.67) Discontinued operations - - - 0.15 Net loss per share $(0.83) $(0.67) $(2.51) $(2.52) Shares used in computing basic and diluted net loss per share 39,062 38,753 38,982 35,493 InterMune, Inc. PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS (unaudite
'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
2. InterMune Announces Issuance of U.S. Patent for ITMN-191
3. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
4. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
5. InterMune to Present at J.P. Morgan Healthcare Conference
6. InterMune to Present at Deutsche Bank Biotech Boston Confab
7. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
8. InterMune to Release Third Quarter 2008 Financial Results on November 6
9. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
10. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
11. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 The first ... a next generation approach to robotics. What sets Droidles ... patent pending technology that allows them to communicate, share ... wirelessly over the internet. , “The invention is the ... the little Droidles a life of their own, both ...
(Date:7/29/2014)... 2014 EXpressLO LLC, expert provider of ... preparation solutions, has been granted patent number 8,789,826 by ... methods incorporating a unique specimen carrier support grid design ... second company patent for EXpressLO LLC awarded to founder ... These complementary patents extend EXpressLO’s portfolio of intellectual property. ...
(Date:7/28/2014)... 2014 “2014 Deep Research ... is a professional and in-depth research report ... report introduces Lubricant basic information, including Lubricant ... and industry overview. This research covers the ... as well as global industry analysis covering ...
(Date:7/28/2014)... July 28, 2014 ... Identification Market by Products (Consumables, Instruments, Services), Methods (Phenotypic, ... User (Detection, Characterization) - Global Forecasts to ... Market is estimated at $896.5 Million in ... Million by 2019, growing at a CAGR ...
Breaking Biology Technology:Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2EXpressLO LLC Granted Second U.S. Patent for Innovative Specimen Preparation Methods 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 3Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 4Microbial Identification Market worth $1,194.1 Million by 2019 2Microbial Identification Market worth $1,194.1 Million by 2019 3
... Cell Therapeutics, Inc.,(CTI) (Nasdaq and MTAX: CTIC) ... (the "Letter") from Nasdaq indicating that the Company,s,recently ... Preferred,Stock (the "Series C Preferred") and warrants did ... Nasdaq Marketplace Rule 4351 and IM 4351.,The Nasdaq ...
... Plan Extends Financial Resources Beyond 2008 -, ... Inc. (Nasdaq: SNSS ) today announced that ... and implementing a revised,operating plan that focuses its ... while streamlining the company,s operations and extending,its financial ...
... for Early and Accurate Diagnosis of Peripheral Artery ... Disease ... - Findings Published Online in Circulation -, FREMONT, Calif., Aug. 28 ... research that details how a protein biomarker called beta-2,microglobulin may aid in the ...
Cached Biology Technology:Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination 2Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 2Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 3Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 4Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease 2Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease 3
(Date:7/29/2014)...  When it comes to technology, healthcare is usually one of ... However, when it comes to wearables, healthcare is trying to move ... Internet of Things and its wearable cousins is less than mature, ... industry, whether it,s in the hospital for a major procedure or ... With that in mind, InformationWeek editor Rodney Brown ...
(Date:7/29/2014)... of Kent has shown for the first time how ... that could have a major impact on cancer therapy ... uncovered the mechanism whereby the physical properties of the ... are ,fine-tuned, to undertake different functions. , While ... providing a framework for the cell, others are more ...
(Date:7/29/2014)... for parents of preterm babies latest research from the ... they become teenagers, the brains of many preterm children can ... A study conducted by the University,s Robinson Research Institute ... experiences no brain injury in early life, their cognitive abilities ... term-born peers. , However, the results of the study, published ...
Breaking Biology News(10 mins):Preterm children's brains can catch up years later 2
... involved in cellular immune signaling, scientists have succeeded in making ... protein with a new twist may eventually be used to ... involved in immune responses that are initiated by proteins called ... the immune system in response to challenges by foreign agents ...
... properties of human bone has been made by scientists ... scientists describe their results –?finding a sort of "glue" ... August issue of the international scientific journal, Nature Materials. ... It describes how healthy bone resists fracture and how ...
... Georgia Institute of Technology and the John Innes Centre ... which disease-causing bacteria may thwart the body's natural defense ... development of more effective antibiotics, appear in the September ... oxide is produced by the body to fight infections. ...
Cached Biology News:Engineered molecule amplifies body's immune response 2Engineered molecule amplifies body's immune response 3Fundamental discovery -- Bone fracture 2Fundamental discovery -- Bone fracture 3Researchers uncover E. coli's defense mechanism 2
Purified anti-DNA-PKcs Phosphorylated (Thr2609)...
Purified anti-PI3K p110 delta...
Biotin anti-mouse Ly-49C/F/I/H...
... Purified Tyrosine Hydroxylase (Ser40) Polyclonal ... raised against synthetic phosphopeptide corresponding ... the phospho-Ser40 of rat Tyrosine ... purified by sequential chromatography on ...
Biology Products: